The present invention relates to a novel bacteriophage FCJ27 (KCCM11465P), and a composition containing the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by enterotoxigenic Escherichia coli of an animal, excluding humans, by using the bacteriophage FCJ27 (KCCM11465P) or the composition.